Why do patients participate in long-term cardiovascular trials?--a questionnaire-based study

Helena Dellborg1, Görel Hultsberg-Olsson1, Mikael Dellborg1,2

  • 1a Research Unit, Department of Medicine/Östra , Sahlgrenska University Hospital/Östra , Gothenburg , Sweden ;

Insights

Patients in cardiovascular clinical trials value continuous care from familiar doctors and nurses. Altruistic motives, like advancing science, also significantly drive participation in these long-term studies.

Area of Science:

  • Cardiology
  • Clinical Research
  • Patient Engagement

Background:

  • Patient participation is crucial for developing new cardiovascular disease treatments.
  • Long-term clinical trials require high patient retention to yield valid results.
  • Understanding patient motivations can improve trial recruitment and reduce dropout rates.

Purpose of the Study:

  • To identify key motivators for patient participation and retention in long-term cardiovascular clinical trials.
  • To inform strategies for enhancing patient enrollment and adherence in clinical research.

Main Methods:

  • A questionnaire with 11 statements was administered to 135 participants in cardiovascular clinical trials.
  • Participants' reasons for joining and remaining in trials were assessed.
  • Demographic data including age and gender were collected.

Main Results:

  • The primary motivator for participation was consistent access to their doctor and nurse (66%).
  • A strong secondary motivator was the desire to advance scientific knowledge (55%).
  • Free visits were the least significant factor influencing participation.

Conclusions:

  • Continuous care and a familiar healthcare team are significant drivers for patient involvement in cardiovascular trials.
  • Altruistic motivations, such as contributing to scientific progress, are equally important for patient retention.
  • Addressing these motivators can enhance patient recruitment and long-term commitment in clinical research.
Abstract

Related Concept Videos

Longitudinal Studies01:26

Longitudinal Studies

Longitudinal studies are also widely used in other medical and social science fields. For instance, in cardiovascular research, they can monitor patients' health over decades to identify risk factors for heart disease, such as high cholesterol or smoking, and evaluate the long-term effectiveness of preventive measures. Similarly, in mental health studies, researchers might follow individuals from adolescence into adulthood to understand the development and progression of conditions like...
656
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
1.1K
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
208
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.4K
Longitudinal Research02:20

Longitudinal Research

Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
13.7K
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
11.1K